UTime Limited Launches Smartwatch with Integrated Blood Pressure Monitoring
UTime (Nasdaq: WTO) launched a smartwatch with integrated blood pressure monitoring on Oct 28, 2025, expanding its health tech product lineup.
The device uses the oscillometric method with an integrated micro air pump and high-precision pressure sensor, and it holds a China NMPA Class II Medical Device Registration (Registration Certificate No. Guangdong Instrument Note No. 20162070928). The watch also reports heart rate, blood oxygen saturation, sleep analysis, and multiple sports modes while emphasizing wearing comfort and interactive features like voice reminders.
UTime (Nasdaq: WTO) ha lanciato uno smartwatch con monitoraggio integrato della pressione sanguigna il 28 ottobre 2025, ampliando la sua linea di prodotti tecnologici per la salute.
Il dispositivo utilizza il metodo oscillometrico con una micro pompa d'aria integrata e un sensore di pressione ad alta precisione, e possiede una Registrazione come Dispositivo Medico di Classe II della NMPA cinese (Certificato di Registrazione n. Guangdong Instrument Note n. 20162070928). L'orologio riporta anche frequenza cardiaca, saturazione di ossigeno nel sangue, analisi del sonno e molteplici modalità sportive, ponendo l'accento sul comfort di indossamento e su caratteristiche interattive come promemori vocali.
UTime (Nasdaq: WTO) lanzó un reloj inteligente con monitorización integrada de la presión arterial el 28 de octubre de 2025, ampliando su línea de productos de tecnología de la salud.
El dispositivo utiliza el método oscilométrico con una microbomba de aire integrada y un sensor de presión de alta precisión, y cuenta con una Registro de Dispositivo Médico de Clase II de la NMPA China (Certificado de Registro No. Guangdong Instrument Note No. 20162070928). El reloj también reporta ritmo cardíaco, saturación de oxígeno en la sangre, análisis del sueño y múltiples modos deportivos, enfatizando la comodidad de uso y funciones interactivas como recordatorios por voz.
UTime (나스닥: WTO)가 2025년 10월 28일에 혈압 모니터링이 통합된 스마트워치를 출시하여 건강 기술 포트폴리오를 확장했습니다.
이 기기는 맥동측정(osillometric) 방법을 사용하고, 통합된 소형 공기 펌프와 고정밀 압력 센서를 갖추고 있으며, 중국 NMPA 제2등급 의료기기 등록증(등록증 번호 Guangdong Instrument Note No. 20162070928)을 보유하고 있습니다. 이 시계는 심박수, 혈중 산소포화도, 수면 분석, 다양한 스포츠 모드를 제공하며 착용 편안함과 음성 알림과 같은 대화형 기능에 중점을 두고 있습니다.
UTime (Nasdaq : WTO) a lancé une montre connectée avec surveillance intégrée de la pression artérielle le 28 octobre 2025, élargissant sa gamme de produits technologiques de santé.
L'appareil utilise la méthode oscillométrique avec une micro-pompe à air intégrée et un capteur de pression haute précision, et détient une Enregistrement de dispositif médical de Classe II NMPA chinoise (Numéro d'enregistrement Guangdong Instrument Note No. 20162070928). La montre indique aussi le rythme cardiaque, la saturation en oxygène, l'analyse du sommeil et plusieurs modes sportifs, tout en mettant l'accent sur le confort de port et des fonctionnalités interactives comme des rappels vocaux.
UTime (Nasdaq: WTO) hat am 28. Oktober 2025 eine Smartwatch mit integrierter Blutdrucküberwachung eingeführt und damit sein Health-Tech-Produktportfolio erweitert.
Das Gerät verwendet die oszillometrische Methode mit einer integrierten Mikro-Luftpumpe und einem hochpräzisen Drucksensor und führt eine Registrierung als Medizinprodukt der Klasse II der chinesischen NMPA (Registrierungszertifikat Nr. Guangdong Instrument Note Nr. 20162070928) durch. Die Uhr meldet außerdem Herzfrequenz, Blutsauerstoffsättigung, Schlafanalyse und mehrere Sportmodi, wobei Tragekomfort und interaktive Funktionen wie Spracherinnerungen im Vordergrund stehen.
UTime (ناسداك: WTO) أطلقت ساعة ذكية مع مراقبة ضغط الدم مدمجة في 28 أكتوبر 2025، مما يوسع مجموعة منتجاتها في تقنية الصحة.
تستخدم الجهاز طريقة القياس بالتذبذبات الاهتزازية (oscillometric) مع مضخة هواء ميكروية مدمجة ومسبار ضغط عالي الدقة، وتملك تسجيل جهاز طبي من الفئة II لدى NMPA الصينية (شهادة التسجيل رقم 20162070928 Guangdong Instrument Note). كما تقيس الساعة معدل ضربات القلب، تشبع الأكسجين في الدم، تحليل النوم، والعديد من أوضاع الرياضة، مع التركيز على راحة الارتداء وميزات تفاعلية مثل التذكيرات الصوتية.
UTime (纳斯达克: WTO) 于 2025年10月28日 推出了一款具备血压监测功能的智能手表，扩大了其健康科技产品阵容。
该设备使用 Oscillometric 方法，配备集成微型气泵和高精度压力传感器，并拥有中国国家药品监督管理局（NMPA）二类医疗器械注册证（注册证号：广东仪器笔记号 20162070928）。手表还可监测心率、血氧饱和度、睡眠分析以及多种运动模式，同时强调佩戴舒适度和诸如语音提醒等互动功能。
- China NMPA Class II medical registration (Reg. No. 20162070928)
- Uses market-validated oscillometric blood pressure method
- Integrated micro air pump and high-precision pressure sensor
- None.
SHENZHEN, China, Oct. 28, 2025 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO), a global technology company engaged in the design and development of mobile devices, today announced the launch of a smartwatch with integrated blood pressure monitoring functionality, further expanding its product portfolio in the health technology sector.
The product utilizes the Oscillo metric method, a market-validated measurement principle, and integrates a micro air pump and high-precision pressure sensor to provide users with a convenient blood pressure monitoring experience. It has obtained China NMPA Class II Medical Device Registration Certificate (Registration Certificate No.: Guangdong Instrument Note No. 20162070928). In addition to its core blood pressure monitoring feature, the watch also provides multi-dimensional health data references, including heart rate, blood oxygen saturation, sleep analysis, and multiple sports mode tracking. The product design balances wearing comfort with daily practicality and includes interactive features such as voice reminders.
Mr. Hengcong Qiu, Chief Executive Officer of UTime Limited, stated, "We focus on integrating practical health monitoring functions with mobile smart devices. The launch of this watch represents our efforts to meet the growing user demand for health management."
About UTime Limited
Operating under the NASDAQ ticker WTO, UTime Limited is engaged in the design, development, production, sales and brand operation of mobile devices in China and globally. The company aims to provide cost-effective products and serves a broad customer base.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. For additional risk factors, please review UTime Limited’s Annual Report on Form 20-F and other SEC filings. Forward-looking statements are made only as of the date of this release.The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required under applicable law.
Contact:
qhengcong@utimemobile.com
UTime Limited
7th Floor, Building 5A
Shenzhen Software Industry Base, Nanshan District
Shenzhen, People’s Republic of China 518061
Tel: (86) 755 86512266
Attachment
FAQ
What blood pressure technology does UTime smartwatch (WTO) use?
Has the UTime smartwatch with BP monitoring received regulatory approval in China?
When did UTime announce the new smartwatch with blood pressure monitoring (WTO)?
What additional health metrics does the UTime WTO smartwatch provide?
Does the UTime smartwatch include user-friendly features for daily use?
Is the UTime smartwatch positioned as a medical device or a consumer wearable (WTO)?
